Topiramate
- PMID:30000318
- Bookshelf ID: NBK501259
Topiramate
Excerpt
Maternal doses of topiramate up to 200 mg daily produce low levels in infant serum. Sedation and diarrhea have been reported occasionally in breastfed infants, but most infants tolerate the drug in milk well. In a few infants, no long-term adverse effects on growth and development have been seen. Monitor the infant for diarrhea, drowsiness, irritability, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsant or psychotropic drugs.
References
- Öhman I, Vitols S, Luef G, et al. Topiramate kinetics during delivery, lactation, and in the neonate: Preliminary observations. Epilepsia 2002;43:1157–60. - PubMed
- Fröscher W, Jürges U. Topiramate used during breast feeding. Aktuel Neurol 2006;33:215–7.
- Kacirova I, Grundmann M, Brozmanova H, et al. Monitoring topiramate concentrations at delivery and during lactation. Biomed Pharmacother 2021;138:111446. - PubMed
Publication types
LinkOut - more resources
Full Text Sources